METADAP - Do Antidepressants Induce Metabolic Syndromes?

Head :
Corruble Emmanuelle, INSERM U669 CHU DE BICETRE - SERVICE DE PSYCHIATRIE

Last update : 07/09/2014 | Version : 1 | ID : 60183

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Do Antidepressants Induce Metabolic Syndromes?
Sign or acronym METADAP
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL
General Aspects
Medical area Endocrinology and metabolism
Health determinants Intoxication
Others (details) Metabolic syndromes
Keywords criteria, definition, Health episodes, pharmacology, side effects
Scientific investigator(s) (Contact)
Name of the director Corruble
Surname Emmanuelle
Address 94275 LE KREMLIN BICETRE
Phone + 33 (0)1 45 21 25 24
Email emmanuelle.corruble@bct.aphp.fr
Unit INSERM U669
CHU DE BICETRE - SERVICE DE PSYCHIATRIE
Organization INSERM - Institut National de la Santé et de la Recherche
Collaborations
Funding
Funding status Public
Details Ministère de la Santé (PHRC NATIONAL)
Governance of the database
Sponsor(s) or organisation(s) responsible AP-HP
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Prospective Inclusion cut-off date: 01/11/2011
Database objective
Main objective General objective: to assess the impact of antidepressants in terms metabolic syndromes. Secondary objective: to identify clinical, genetic and biological predictive factors concerning the onset of metabolic syndromes.
Inclusion criteria Depressed patients requiring antidepressant treatment
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Population covered Sick population
Gender Male
Woman
Geography area National
Detail of the geography area Multicentric cohort throughout France (6 centres): 3 centres in the Paris region and 3 in the province.
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 11/2007
Size of the database
Size of the database (number of individuals) < 500 individuals
Details of the number of individuals 248
Data
Database activity Data collection completed
Type of data collected Clinical data
Declarative data
Biological data
Clinical data (detail) Direct physical measures
Medical registration
Declarative data (detail) Paper self-questionnaire
Biological data (detail) Type of samples taken: glucose level, cholesterol level, triglyceride level
Presence of a biobank Yes
Contents of biobank Serum
Plasma
DNA
Details of biobank content Serum bank, plasma bank, DNA bank
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method Self-administered questionnaire: direct input Interview: direct input Clinical examinations: direct input Biological analysis: direct input
Participant monitoring Yes
Details on monitoring of participants Follow-up duration: 6 months
Links to administrative sources No
Promotion and access
Promotion
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/18707937
Access
Terms of data access (charter for data provision, format of data, availability delay) To be decided if data may be used by academic teams To be decided if data may be used by industrial teams
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05